CRT 2024

Priority Questions for MCS in 2024: An FDA Perspective

Speaker(s)

• 

  Mauro Moscucci, MD, MBA, MPH

  Medical Officer
  Food and Drug Administration, Center for Devices and Radiological Health, Maryland, United States

  Disclosure(s): No financial relationships to disclose